Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) has been assigned a consensus rating of “Hold” from the six research firms that are covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $5.1875.
A number of analysts have weighed in on ASPN shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a report on Wednesday. Wall Street Zen upgraded Aspen Aerogels from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Barclays increased their price target on Aspen Aerogels from $3.00 to $4.00 and gave the stock an “underweight” rating in a report on Monday, May 11th. Finally, Roth Mkm reiterated a “buy” rating and set a $5.75 price target on shares of Aspen Aerogels in a report on Friday, May 8th.
Read Our Latest Analysis on ASPN
Hedge Funds Weigh In On Aspen Aerogels
Aspen Aerogels Stock Performance
Shares of Aspen Aerogels stock opened at $5.62 on Monday. The company has a current ratio of 2.89, a quick ratio of 2.54 and a debt-to-equity ratio of 0.32. The business has a 50-day moving average price of $5.20 and a two-hundred day moving average price of $3.99. Aspen Aerogels has a 1-year low of $2.30 and a 1-year high of $9.78. The company has a market cap of $465.37 million, a P/E ratio of -4.13 and a beta of 3.02.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The construction company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Aspen Aerogels had a negative return on equity of 22.16% and a negative net margin of 48.64%.The business had revenue of $37.88 million for the quarter, compared to analyst estimates of $36.58 million. During the same quarter in the previous year, the business posted ($0.06) earnings per share. The business’s revenue was down 51.8% on a year-over-year basis. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. As a group, analysts anticipate that Aspen Aerogels will post -0.8 EPS for the current year.
About Aspen Aerogels
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
Read More
- Five stocks we like better than Aspen Aerogels
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
